Lek Pharmaceuticals D.D.
Lek Pharmaceuticals D.D. (Slovenia) holds 26 active US FDA Type II Drug Master Files and 17 inactive and has DMF or CEP filings on record for 31 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Lek Pharmaceuticals D.D.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/lek-pharmaceuticals-d-d
Overview
Lek Pharmaceuticals D.D. is a subsidiary of Novartis AG and is based in Slovenia. It is involved in the development, production, and marketing of generic drugs and pharmaceutical products in various therapeutic areas.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Lek Pharmaceuticals D.D. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Lek Pharmaceuticals D.D. holds 26 active (43 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- POTASSIUM CLAVULANATE DILUTED WITH SILICON DIOXIDE IN THE RATIO 1:1Active2023-09-27
- POTASSIUM CLAVULANATE DILUTED WITH MICROCRYSTALLINE CELLULOSE IN THE RATIO 1:1Active2023-01-17
- TACROLIMUS (PROCESS II)Active2020-08-06
- SUGAMMADEX SODIUMActive2019-06-05
- CLAVULANATE POTASSIUM DILUTED WITH SILICON DIOXIDE 1:1Active2018-05-17
- FERRIC CARBOXYMALTOSEActive2018-03-29
- APREMILASTActive2017-09-27
- VORTIOXETINE HYDROBROMIDEActive2017-03-01
- DOLUTEGRAVIR SODIUMActive2016-12-19
- ROSUVASTATIN CALCIUM (PROCESS C)Active2016-12-01
- CLAVULANATE POTASSIUM DILUTED WITH MICROCRYSTALLINE CELLULOSE 1:1Active2015-08-20
- TICAGRELORActive2015-02-06
- ENTECAVIR MONOHYDRATEActive2013-12-17
- FERUMOXYTOLActive2013-11-26
- MYCOPHENOLATE MOFETIL (PROCESS B), USPActive2011-09-27
- ROSUVASTATIN CALCIUMActive2007-08-09
- TACROLIMUSActive2006-11-20
- ATORVASTATIN CALCIUMActive2005-02-01
- VANCOMYCIN HYDROCHLORIDEActive2004-06-22
- TAMSULOSIN HYDROCHLORIDEActive2004-04-09
- LITHIUM CARBONATE A SUBSTANCEActive2001-10-18
- CLAVULANATE POTASSIUMActive2000-12-26
- CLAVULANATE POTASSIUMActive2000-01-19
- GENTAMICIN SULFATEActive1998-09-01
- BROMOCRIPTINE MESYLATE USPActive1987-02-13
- SILVER SULFADIAZINEActive1981-09-29
- ROSUVASTATIN CALCIUM (PROCESS B)Inactive2014-05-08
- FESOTERODINE FUMARATEInactive2012-09-27
- CASPOFUNGIN ACETATEInactive2009-10-28
- TOLTERODINE TARTRATEInactive2007-12-21
- OLANZAPINEInactive2007-03-16
- CANDESARTAN CILEXETILInactive2006-12-18
- MYCOPHENOLATE MOFETILInactive2005-11-07
- LOSARTAN POTASSIUMInactive2004-12-01
- LOVASTATINInactive2004-09-08
- SIMVASTATINInactive2004-07-27
- AMLODIPINE BESYLATEInactive2003-10-02
- PRAVASTATIN SODIUMInactive2002-10-22
- DIHYDROERGOTAMINE MESYLATEInactive2002-10-17
- PRAVASTATIN SODIUMInactive2002-04-03
- LISINOPRIL A DRUG SUBSTANCEInactive2000-09-07
- ENALAPRIL MALEATE, A SUBSTANCEInactive1998-08-06
- VANCOMYCIN HYDROCHLORIDEInactive1998-04-30
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Lek Pharmaceuticals D.D. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Lek Pharmaceuticals D.D.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.